Facebook Pixel AI does not just make clinical trials faster; t makes them smarter | Express Pharma - health - Bu hikayeyi Magzter.com'da okuyun

Denemek ALTIN - Özgür

AI does not just make clinical trials faster; t makes them smarter

Express Pharma

|

April 2025

Santhosh AF, VP, Asia Pacific South & India, Medidata highlights how AI is improving the efficiency and speed of the clinical trial process from early drug discovery to data analysis and decision-making. He also explains Medidata's contributions towards a digital transformation of the clinical research landscape, in an interview with Kavita Jani

AI does not just make clinical trials faster; t makes them smarter

What are the major advancements in drug development research? What are the opportunities for India in the current landscape?

Drug development research has made remarkable progress globally, with India emerging as a key contributor. According to Deloitte, India's pharmaceutical research and development (R&D) market is estimated to expand to $130 billion by 2030, and the country is considered the third-largest global producer of drugs by volume").

The biggest shift we are seeing in drug development is the introduction and increasing adoption of advanced technologies, such as artificial intelligence (AI), data analytics, telemedicine, and wearables and sensor technologies. While still relatively in the early stages in India compared to other markets, we are already seeing great appetite on the ground and tremendous opportunities to revolutionise drug development research. Benefits of AI include accelerating insights by processing colossal amounts of data within seconds, a number that would take humans years to process, while telemedicine and wearables enable hybrid and decentralised trials which make them more accessible to participants.

What are the challenges in the current clinical trial landscape in India? How can they be tackled?

While the talent pool has grown, the industry still grapples with skill gaps and high attrition rates of around 30 per cent, higher than the global average of 12 per cent (1). One way to tackle attrition is through the incorporation of technology that will enable talent to do their work more efficiently, thereby helping to mitigate stress and burnout.

For example, AI can help automate time-consuming and traditionally manual tasks such as the collection, organisation, and analysis of data, minimising human error and providing real-time insights.

Express Pharma'den DAHA FAZLA HİKAYE

Express Pharma

Express Pharma

Standardisation vs customisation in single-use systems for bioprocessing: What do biopharma companies need?

Priyabrata Pattnaik, CEO, Ami Polymer highlights the balance between standardisation and customisation in single - use systems in biopharma manufacturing

time to read

5 mins

May 2026

Express Pharma

Express Pharma

Ensuring Pharma compliance with testo data measurement technology

Due to the crucial necessity and its direct impact on human health and welfare, Pharma is probably the most important and critical sector among others.

time to read

3 mins

May 2026

Express Pharma

Express Pharma

China+1 moment for pharma: How India can convert opportunity into long-term contracts

Manish Jain, Director, Naprod Life Sciences explains how India must move beyond cost advantage to lead with reliability, quality, and transparency to reshape global pharma supply chains and position itself as a trusted, long-term partner

time to read

3 mins

May 2026

Express Pharma

Express Pharma

Beyond scale: Rethinking new frontiers in building excellence

At the Injectable Innovations Conclave 2026, hosted by Express Pharma, industry leaders examined the trends, technologies and strategies shaping the next phase of injectable growth, reports

time to read

10 mins

May 2026

Express Pharma

Express Pharma

Waters receives CE mark for BD BACTEC FXI Culture System under EU IVDR

Next-generation blood culture system records ~3-hour faster detection time and introduces automated blood volume measurement

time to read

2 mins

May 2026

Express Pharma

Express Pharma

JNPC: Carrying forward a 20-year old legacy

Billed as India's first bulk drug, chemicals and allied manufacturing parks and one of the most successful public-private partnerships (PPP) in the pharma sector, the Jawaharlal Nehru Pharma City (JNPC), also known as Visakha Pharma City, was set up in February 2005 as a PPP initiative by the Govt of Andhra Pradesh (GoAP) through its nodal agency Andhra Pradesh Industrial Infrastructure Corporation (APIIC) with the Ramky Group on a Build-Own-Operate (BOO) basis for 20 years.

time to read

3 mins

May 2026

Express Pharma

Express Pharma

Romaco's sustainable blister packaging line at interpack

At this year's interpack, the Romaco Group will present its sustainable Unity 600 high-speed blister packaging line, featuring – for the first time – the PF 75 stretch bander.

time to read

6 mins

May 2026

Express Pharma

Express Pharma

Even drug-resistant cancer targets can be tackled with the right design strategy

Dr Bajarang Kumbhar, Assistant Professor, Sunandan Divatia School of Science, NMIMS Mumbai, explains how Al-driven computational biology is reshaping CAR-T therapy and highlights how these approaches help cut drug discovery timelines and improve targeted, personalised cancer treatment, in an interaction with Kalyani Sharma

time to read

7 mins

May 2026

Express Pharma

Express Pharma

Navigating legal and regulatory landscape of GLP-1 drugs in India

GLP-1 drugs are drawing sharp regulatory and legal scrutiny, especially with generics entering post-patent expiry. They emphasise that navigating IP, compliance, and marketing rules is now critical for stakeholders

time to read

5 mins

May 2026

Express Pharma

Express Pharma

From back office to brain trust: How life sciences GCCs are redefining leadership hiring in India

Sai Gandhi, Partner, Positive Moves points out that life sciences GCCs in India are moving from support roles to driving core innovation and global strategy. In turn, leadership hiring is shifting toward cross-functional, globally savvy leaders who can deliver enterprise-wide impact

time to read

4 mins

May 2026

Listen

Translate

Share

-
+

Change font size